Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialJordana B. Cohen, Julio A. Chirinos, Juan E. Rodriguez‐Mori et al.|The Lancet Respiratory Medicine|2021Cited by 224
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial ProtocolJordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|Journal of Clinical Hypertension|2020Cited by 19
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin SystemDaniel Edmonston, Jordana B. Cohen, Andrew M. South et al.|Advances in Chronic Kidney Disease|2020Cited by 18